Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -22.08% is 13% above its 5-year average of -25.49%, around the middle of its 5-year range (-49.71%–-0.59%).
3.23% above its 12-month average of -22.82%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -5.75%.
OPERATING MARGIN
-22.08%
OPERATING MARGIN AVG TTM
-22.82%
OPERATING MARGIN AVG 3Y
-29.61%
OPERATING MARGIN AVG 5Y
-25.49%
OPERATING MARGIN AVG 10Y
-18.72%
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+3.23%
CURRENT VS 3Y AVG
+25.43%
CURRENT VS 5Y AVG
+13.37%
CURRENT VS 10Y AVG
-17.92%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 841 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Novocure Ltd
Market Cap
$1.77B
Operating Margin
-22.08%
TTM Avg
-22.82%
3Y Avg
-29.61%
5Y Avg
-25.49%
Market Cap
$1.78B
Operating Margin
-4454.21%
TTM Avg
-3427.90%
3Y Avg
-2683.37%
5Y Avg
-2097.52%
Market Cap
$1.78B
Operating Margin
-737.04%
TTM Avg
-849.82%
3Y Avg
-849.82%
5Y Avg
-849.82%
Market Cap
$1.76B
Operating Margin
11.89%
TTM Avg
11.48%
3Y Avg
12.13%
5Y Avg
11.99%
Market Cap
$1.79B
Operating Margin
-141.35%
TTM Avg
-151.41%
3Y Avg
-107.18%
5Y Avg
-79.23%
Market Cap
$1.75B
Operating Margin
10.91%
TTM Avg
-4.02%
3Y Avg
-27.30%
5Y Avg
-125.05%
Market Cap
$1.74B
Operating Margin
1.20%
TTM Avg
-1.69%
3Y Avg
-4.84%
5Y Avg
-5.86%
Market Cap
$1.80B
Operating Margin
50.14%
TTM Avg
6.82%
3Y Avg
-32.12%
5Y Avg
-473.91%
Market Cap
$1.82B
Operating Margin
29.46%
TTM Avg
25.49%
3Y Avg
21.64%
5Y Avg
22.06%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Novocure Ltd (NVCR) | $1.77B | -22.08% | -22.82% | -29.61% | -25.49% |
| Absci Corporation (ABSI)vs › | $1.78B | -4454.21% | -3427.90% | -2683.37% | -2097.52% |
| Generate Biomedicines, Inc. (GENB)vs › | $1.78B | -737.04% | -849.82% | -849.82% | -849.82% |
| Surgery Partners, Inc. (SGRY)vs › | $1.76B | 11.89% | 11.48% | 12.13% | 11.99% |
| Xencor, Inc. (XNCR)vs › | $1.79B | -141.35% | -151.41% | -107.18% | -79.23% |
| Xeris Biopharma Holdings, Inc. (XERS)vs › | $1.75B | 10.91% | -4.02% | -27.30% | -125.05% |
| Alignment Healthcare, Inc. (ALHC)vs › | $1.74B | 1.20% | -1.69% | -4.84% | -5.86% |
| Novavax, Inc. (NVAX)vs › | $1.80B | 50.14% | 6.82% | -32.12% | -473.91% |
| LeMaitre Vascular, Inc. (LMAT)vs › | $1.82B | 29.46% | 25.49% | 21.64% | 22.06% |
| Sarepta Therapeutics, Inc. (SRPT)vs › | $1.82B | -29.92% | -9.23% | -24.36% | -44.57% |
Gross Margin
76.1%
Operating Margin
-22.1%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -5.75% |
| 2026-03-31 | -38.73% |
| 2025-12-31 | -23.17% |
| 2025-09-30 | -21.54% |
| 2025-06-30 | -24.89% |
| 2025-03-31 | -24.43% |
| 2024-12-31 | -39.25% |
| 2024-09-30 | -20.69% |
| 2024-06-30 | -22.35% |
| 2024-03-31 | -29.98% |
| 2023-12-31 | -38.66% |
| 2023-09-30 | -45.75% |
| 2023-06-30 | -49.71% |
| 2023-03-31 | -49.31% |
| 2022-12-31 | -33.46% |
| 2022-09-30 | -18.79% |
| 2022-06-30 | -15.00% |
| 2022-03-31 | -0.59% |
| 2021-12-31 | -17.56% |
| 2021-09-30 | -6.40% |
| 2021-06-30 | -9.21% |
| 2021-03-31 | -0.07% |
| 2020-12-31 | 8.40% |
| 2020-09-30 | 11.32% |
| 2020-06-30 | 5.75% |
| 2020-03-31 | -3.32% |
| 2019-12-31 | 0.15% |
| 2019-09-30 | 4.19% |
| 2019-06-30 | 1.38% |
| 2019-03-31 | -8.35% |
| 2018-12-31 | -12.44% |
| 2018-09-30 | -8.10% |
| 2018-06-30 | -11.52% |
| 2018-03-31 | -24.32% |
| 2017-12-31 | -8.40% |
| 2017-09-30 | -11.81% |
| 2017-06-30 | -40.47% |
| 2017-03-31 | -38.34% |
| 2016-12-31 | -59.11% |
| 2016-09-30 | -130.41% |
| 2016-06-30 | -207.81% |
| 2016-03-31 | -244.68% |
| 2015-12-31 | -247.16% |
| 2015-09-30 | -270.72% |
| 2015-06-30 | -415.80% |
| 2015-03-31 | -421.39% |
| 2014-12-31 | -605.34% |
| 2014-09-30 | -409.35% |
| 2014-06-30 | -515.26% |
| 2014-03-31 | -563.55% |
